Ling Yang

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

Andrew X. Zhu, Joon Oh Park, Baek‐Yeol Ryoo et al. · The Lancet Oncology · 2015 · 829 citations · Full text

Oncology, Hepatology, Clinical Trials +10

Natural selection on <i>EPAS1</i> ( <i>HIF2α</i> ) associated with low hemoglobin concentration in Tibetan highlanders

Cynthia M. Beall, Gianpiero L. Cavalleri, Libin Deng et al. · Proceedings of the National Academy of Sciences · 2010 · 824 citations · Full text

Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel

Olivier Delaneau, Jonathan Marchini, Gil McVean et al. · Nature Communications · 2014 · 441 citations · Full text

Haplotype Determination, Next-generation Sequencing, Genetics +11

Genomic Dissection of Population Substructure of Han Chinese and Its Implication in Association Studies

Shuhua Xu, Xianyong Yin, Shilin Li et al. · The American Journal of Human Genetics · 2009 · 341 citations · Full text

A Liver-Enriched Long Non-Coding RNA, lncLSTR, Regulates Systemic Lipid Metabolism in Mice

Ping Li, Xiangbo Ruan, Ling Yang et al. · Cell Metabolism · 2015 · 278 citations · Full text

Lipid Synthesis, Liver Physiology, Metabolic Regulation +7